StocksFin Logo
VIR logo
$VIR

Vir Biotechnology, Inc.

VIR country of incorporation
|
https://www.vir.bio
|
Dr. George Scangos
|
444 employees
NASDAQ | Healthcare | Biotechnology
VIR reported its Q322 earnings on November 3, 2022 (105 weeks ago).
$371.43M 258.5% vs. Q321 Revenues Q322
94.01% 1.7% vs. Q321 Gross Profit Margin
47.2% -55.7% vs. Q321 Net Profit Margin
98.91M 188.5% vs. Q321 Free Cash Flow Q322
$1.32 55.3% vs. Q321 EPS Q322
Company Card Q322
As reported on November 3, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
S+
Growth calculated YoY
Company Card Q322
As reported on November 3, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
S+
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
371.43M
+776.1%
22.25M
175.31M
+329.2%
$1.32
Q22022
-54.94M
-104.5%
27.92M
-76.49M
-114.7%
$-0.58
Q12022
1.23B
90.15M
518.62M
$3.93
FY2021
1.1B
 65.87M
528.58M
$4.44
Q42021
812.75M
+684.4%
56.88M
525.25M
+375.7%
$4.01
Q32021
103.62M
-41.5%
7.84M
110.43M
+78.6%
$0.85
Q22021
177.07M
+8860.9%
1.14M
61.81M
+136.6%
$0.48
Q12021
1.98M
0
-168.91M
$-1.32
FY2020
76.37k
 0
-298.67k
$-0
FY2019
8.09M
 0
-174.68M
$-5.76
FY2018
10.67M
 0
-115.88M
$-1.52
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
2.7B
 546.12M
963.74M
131.06M
2.15B
Q22022
2.62B
 666.98M
1.51B
130.21M
1.95B
Q12022
2.89B
 886.12M
812.36M
136.88M
2B
FY2021
1.95B
 522.42M
347.82M
133.56M
1.43B
FY2020
841.07M
 201.91M
436.58M
74.34M
716.85M
FY2019
512.07M
 88.13M
109.34M
474k
423.94M
FY2018
191.6M
 370.77M
47.6M
0
-179.18M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
117.9M
 -662.61M
1.99M
-18.99M
98.91M
-89.5%
Q22022
960.14M
 -272.33M
3.08M
-20.6M
939.54M
+75.9%
Q12022
550.09M
 -105.39M
27.69M
-15.84M
534.25M
FY2021
-47.59M
 -140.81M
100.33M
-21.82M
-69.41M
FY2020
-190.94M
 -9.86M
529.47M
-6.55M
-197.49M
FY2019
-129.63M
 -256.16M
449.24M
-8.94M
-138.57M
FY2018
-94.1M
 -60.44M
24.98M
-8.19M
-102.29M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees